EpCAM immunotherapy versus specific targeted delivery of drugs
Version 3 2024-06-18, 06:35
Version 2 2024-06-04, 11:48
Version 1 2018-01-12, 00:00
journal contribution
posted on 2024-06-18, 06:35 authored by Joanna MacdonaldJoanna Macdonald, J Henri, K Roy, E Hays, Michelle BauerMichelle Bauer, RN Veedu, N Pouliot, Sarah ShigdarEpCAM immunotherapy versus specific targeted delivery of drugs
History
Related Materials
- 1.
Location
SwitzerlandOpen access
- Yes
Link to full text
Language
EnglishPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2018, The AuthorsJournal
CancersVolume
10Article number
ARTN 19Pagination
1 - 13ISSN
2072-6694eISSN
2072-6694Issue
1Publisher
MDPIUsage metrics
Keywords
Science & TechnologyLife Sciences & BiomedicineOncologyantibodyaptamercancerEpCAMimmunotherapytherapeuticsCELL-ADHESION MOLECULETUMOR-ASSOCIATED ANTIGENMONOCLONAL-ANTIBODY 17-1ACANCER-THERAPYBREAST-CANCERSOLID TUMORSCOLON-CANCERMEDIATED CYTOTOXICITYCLINICAL DEVELOPMENTMACROCYCLIC-PEPTIDE3211 Oncology and carcinogenesis3204 Immunology3206 Medical biotechnology
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC